A study based on binary fingerprints for flavone analogues as CDK2/Cyclin a inhibitors. a two dimensional QSAR approach

Research output: Contribution to journalArticle

Abstract

In the present study, we have applied seven available similarity based binary fingerprints as implemented in the new cheminformatics package Canvas, on a validated dataset for the test compounds selectively inhibiting CDK2/Cyclin A. The fingerprint methods used were: Linear, Dendritic, Radial, MOLPRINT2D, Pairwise, Triplet, and Torsion. Out of the seven fingerprints used, the fingerprint dentritic resulted in a statistically significant 2D QSAR model with regression coefficient (r2) value of 0.9284 and cross validation coefficient (q2) value of 0.9865. The model could be used to design potent inhibitors against the target CDK2/Cyclin A as a goal towards development of novel anticancer agents.

Original languageEnglish
Pages (from-to)659-662
Number of pages4
JournalLatin American Journal of Pharmacy
Volume38
Issue number4
Publication statusPublished - 01-01-2019

Fingerprint

flavone
Cyclins
Quantitative Structure-Activity Relationship
Dermatoglyphics
Cyclin A
Antineoplastic Agents

All Science Journal Classification (ASJC) codes

  • Pharmaceutical Science
  • Drug Discovery

Cite this

@article{02cca553bb6c4b8992d7c1be400c5b7e,
title = "A study based on binary fingerprints for flavone analogues as CDK2/Cyclin a inhibitors. a two dimensional QSAR approach",
abstract = "In the present study, we have applied seven available similarity based binary fingerprints as implemented in the new cheminformatics package Canvas, on a validated dataset for the test compounds selectively inhibiting CDK2/Cyclin A. The fingerprint methods used were: Linear, Dendritic, Radial, MOLPRINT2D, Pairwise, Triplet, and Torsion. Out of the seven fingerprints used, the fingerprint dentritic resulted in a statistically significant 2D QSAR model with regression coefficient (r2) value of 0.9284 and cross validation coefficient (q2) value of 0.9865. The model could be used to design potent inhibitors against the target CDK2/Cyclin A as a goal towards development of novel anticancer agents.",
author = "Aravinda Pai and Jayashree, {B. S.}",
year = "2019",
month = "1",
day = "1",
language = "English",
volume = "38",
pages = "659--662",
journal = "Latin American Journal of Pharmacy",
issn = "0326-2383",
publisher = "Colegio de Farmaceuticos de la Provincia de Buenos Aires",
number = "4",

}

TY - JOUR

T1 - A study based on binary fingerprints for flavone analogues as CDK2/Cyclin a inhibitors. a two dimensional QSAR approach

AU - Pai, Aravinda

AU - Jayashree, B. S.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - In the present study, we have applied seven available similarity based binary fingerprints as implemented in the new cheminformatics package Canvas, on a validated dataset for the test compounds selectively inhibiting CDK2/Cyclin A. The fingerprint methods used were: Linear, Dendritic, Radial, MOLPRINT2D, Pairwise, Triplet, and Torsion. Out of the seven fingerprints used, the fingerprint dentritic resulted in a statistically significant 2D QSAR model with regression coefficient (r2) value of 0.9284 and cross validation coefficient (q2) value of 0.9865. The model could be used to design potent inhibitors against the target CDK2/Cyclin A as a goal towards development of novel anticancer agents.

AB - In the present study, we have applied seven available similarity based binary fingerprints as implemented in the new cheminformatics package Canvas, on a validated dataset for the test compounds selectively inhibiting CDK2/Cyclin A. The fingerprint methods used were: Linear, Dendritic, Radial, MOLPRINT2D, Pairwise, Triplet, and Torsion. Out of the seven fingerprints used, the fingerprint dentritic resulted in a statistically significant 2D QSAR model with regression coefficient (r2) value of 0.9284 and cross validation coefficient (q2) value of 0.9865. The model could be used to design potent inhibitors against the target CDK2/Cyclin A as a goal towards development of novel anticancer agents.

UR - http://www.scopus.com/inward/record.url?scp=85065206744&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85065206744&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:85065206744

VL - 38

SP - 659

EP - 662

JO - Latin American Journal of Pharmacy

JF - Latin American Journal of Pharmacy

SN - 0326-2383

IS - 4

ER -